Search
for
Sort by
Research 271–300 of 531
- Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
- Acne Syndromes and Mosaicism
- Case Report: Successful Use of Minoxidil to Promote Facial Hair Growth in an Adolescent Transgender Male
- Annual Convention in the Time of COVID
- Psycho-emotional conditions of patients with non-cicatrazing alopecia (circumsribed, androgenetic)
- Efficacy and safety of oral finasteride <i>versus</i> dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential
- Polycystic ovary syndrome and psychological distress: Urban–rural comparison among reproductive-aged women in Bangladesh
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto ( <i>Serenoa repens</i> ) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self‐Perceived Thinning Hair: 90‐Day Results
- Androgenetic alopecia
- The Biomolecular Effects of Finasteride on Male Rat Brain during Administration and after Discontinuation
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Who Tells the Story of the Treatment of Androgenetic Alopecia?—A Bibliometric Analysis From 2003 to 2023
- Bi-directional association between female pattern hair loss and polycystic ovary syndrome: A systematic review and meta-analysis.
- Trichotillomania in long COVID successfully treated with escitalopram: A case report
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Development of Ethosomes for the Topical Treatment of Androgenic Alopecia: Ethanol Effect on Dutasteride Targeting to the Hair Follicles
- Association between finasteride with subjective memory deficits: a study from the NHANES and FAERS databases
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- Adverse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia - a literature review
- Wokeness in Our Practice
- Post-finasteride syndrome - a true clinical entity?
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- The Nutrient–Skin Connection: Diagnosing Eating Disorders Through Dermatologic Signs
- Commonly encountered symptoms and their management in patients with cirrhosis